Cancer BiologybioRxiv
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments.
S. M. Castenmiller, R. de Groot, A. Guislain…·M. C. Wolkers
This study shows that tumor-infiltrating lymphocytes (TILs) can be effectively generated from metastatic NSCLC lesions regardless of location or prior treatments, with 76% showing anti-tumoral activity.
DOI 10.1016/j.iotech.2022.100090